Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

227.06
-1.3300-0.58%
Post-market: 227.060.00000.00%19:34 EDT
Volume:927.43K
Turnover:211.11M
Market Cap:25.06B
PE:24.11
High:229.80
Open:228.51
Low:226.81
Close:228.39
52wk High:248.84
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.77
T/O Rate:0.84%
Dividend:3.32
Dividend Rate:1.46%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.33
PE(LYR):25.95

Loading ...

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Quest Diagnostics (DGX) and Otsuka Holdings Co (OtherOTSKF)

TIPRANKS
·
Jul 29

Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)

TIPRANKS
·
Jul 29

Quest Diagnostics is Maintained at Neutral by JP Morgan

Dow Jones
·
Jul 28

Quest Diagnostics Inc : JP Morgan Raises Target Price to $250 from $220

THOMSON REUTERS
·
Jul 28

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Rothschild & Co Redburn Adjusts Quest Diagnostics Price Target to $251 From $233, Maintains Buy Rating

MT Newswires Live
·
Jul 27

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Roche Holding AG (OtherRHHVF) and Quest Diagnostics (DGX)

TIPRANKS
·
Jul 24

Quest Diagnostics is Maintained at Neutral by Baird

Dow Jones
·
Jul 24

Quest Diagnostics Lifts Outlook After Strong Earnings

TIPRANKS
·
Jul 24

Quest Diagnostics Declares Gross Dividend of R$ 1.48 Per Unit, Payable July 28

Reuters
·
Jul 24

Quest Diagnostics price target raised to $245 from $225 at Jefferies

TIPRANKS
·
Jul 24

Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning

Benzinga Earnings
·
Jul 24

Evercore ISI Cuts Quest Diagnostics Price Target to $240 From $225

MT Newswires Live
·
Jul 24

Quest Diagnostics up over 10%, on Pace for Record High Close

Dow Jones
·
Jul 23

Stock Track | Quest Diagnostics Soars 11.54% Intraday After Q2 Earnings Crush Estimates and Full-Year Guidance Lifted

Stock Track
·
Jul 23

Movement Alert|Quest Diagnostics Rises 8.71% in Regular Trading, Q2 Earnings Beat Expectations by 10% with Full-Year Guidance Raised

Market Focus
·
Jul 23

Quest Diagnostics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 23

Quest Diagnostics Exec Says Fewer Physician Requests are Being Offset by More Tests Per Request in Aca Exchange Business - Conf Call

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Exec Says Health Plan Pricing Remains Flat to Slightly Positive, Hospital Reference Business Pricing Slightly Negative - Conf Call

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Exec Says Expects Nova Expenses in Second Half to Account for About 70% of Full-year Total, vs Prior Expectation of 60% - Conf Call

THOMSON REUTERS
·
Jul 23